Two New Ophthalmic Surgical Products Approved by FDA

The FDA has approved Akten Ophthalmic Gel 3.5% — a topical, ocular anesthetic formulation — and Healon D viscoelastic — a clear dispersive ophthalmic viscosurgical device.

Advertisement

Akten is a novel, unit-dose, preservative-free lidocaine gel product, stored at room temperature and intended to be used in any ocular procedure that requires a topical anesthetic agent, according to Akorn, the product’s maker. Akten can be used in cataract surgery, refractive surgery, Lasik surgery, and intravitreal injection.

Healon D’s formula provides exceptional clarity in the surgical field and a high degree of protection of corneal endothelial cells, says Advanced Medical Optics, the product’s manufacturer. Due to its low molecular weight, Healon D coats the cornea and remains in place throughout the entire surgical Process; its lower viscosity is said to provide ideal lubrication of IOL insertion systems. Healon D is latex-free.

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Advertisement

Next Up in Uncategorized

Advertisement

Comments are closed.